0001493152-24-028205.txt : 20240717 0001493152-24-028205.hdr.sgml : 20240717 20240717171012 ACCESSION NUMBER: 0001493152-24-028205 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240715 FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tenjarla Srini CENTRAL INDEX KEY: 0002029985 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38519 FILM NUMBER: 241122922 MAIL ADDRESS: STREET 1: 601 GENOME WAY SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Serina Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821436829 STATE OF INCORPORATION: AL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 BUSINESS PHONE: (256) 327-9630 MAIL ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 FORMER COMPANY: FORMER CONFORMED NAME: AgeX Therapeutics, Inc. DATE OF NAME CHANGE: 20170606 4 1 ownership.xml X0508 4 2024-07-15 0 0001708599 Serina Therapeutics, Inc. SER 0002029985 Tenjarla Srini 601 GENOME WAY, SUITE 2001 HUNTSVILLE AL 35806 0 1 0 0 SVP, CMC & Formulation 0 Stock Option (right to buy) 9.50 2024-07-15 4 A 0 185000 0 A 2034-07-15 Common Stock 185000 185000 D The stock options vest as to 61,666 of the underlying shares on July 15, 2025, and thereafter in substantially equal installments such that the stock options shall be fully vested on the third anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. /s/ Srini Tenjarla 2024-07-17